SLC7A11 and cancer: This suggests that SLC7A11-high tumors are likely resistant to therapies that induce ferroptosis and apoptosis and that this vulnerability of cancer cells to disulfidptosis offers new therapeutic opportunities for treating SLC7A11-high cancers.